Maternal microchimerism: Friend or foe in type 1 diabetes?

Chimerism

Volumn 5, Issue 2, 2014, Pages

  Ye, Jody ^a   Vives Pi, Marta ^b   Gillespie, Kathleen M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Maternal microchimerism; Type 1 diabetes

Indexed keywords

CD45 ANTIGEN; HLA ANTIGEN; INSULIN;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MICROCHIMERISM; MOLECULAR MIMICRY; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; T LYMPHOCYTE; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; MALE; PANCREAS; PREGNANCY;

DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; MALE; MATERNAL-FETAL EXCHANGE; PANCREAS; PREGNANCY;

EID: 84926259260     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.29870     Document Type: Note

References (28)

1. Ye J, Vives-Pi M, Gillespie KM. Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells. PLoS One 2014; 9:e86985; PMID:24498006; http://dx.doi.org/10.1371/journal.pone.0086985
2. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20:87-93; PMID:7193616; http://dx.doi. org/10.1007/BF00262007
3. Czyz W, Morahan JM, Ebers GC, Ramagopalan SV. Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences. BMC Med 2012; 10:93; PMID:22898292; http://dx.doi. org/10.1186/1741-7015-10-93
4. Coppieters KT, Boettler T, von Herrath M. Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med 2012; 2:a007682; PMID:22315719; http://dx.doi.org/10.1101/cshperspect.a007682
5. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721-8; PMID:14519706; http://dx.doi. org/10.1001/jama.290.13.1721
6. Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, et al.; TRIGR Study Group. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA 2014; 311:2279-87; PMID:24915259; http://dx.doi. org/10.1001/jama.2014.5610
7. Frederiksen B, Kroehl M, Lamb MM, Seifert J, Barriga K, Eisenbarth GS, Rewers M, Norris JM. Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY). JAMA Pediatr 2013; 167:808-15; PMID:23836309; http://dx.doi.org/10.1001/ jamapediatrics.2013.317
8. Endesfelder D, zu Castell W, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, et al. Compromised gut microbiota networks in children with antiislet cell autoimmunity. Diabetes 2014; 63:2006-14; PMID:24608442; http://dx.doi.org/10.2337/ db13-1676
9. Stene LC, Gale EA. The prenatal environment and type 1 diabetes. Diabetologia 2013; 56:1888-97; PMID:23657800; http://dx.doi.org/10.1007/ s00125-013-2929-6
10. Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 2005; 54(Suppl 2):S52-61; PMID:16306341; http://dx.doi. org/10.2337/diabetes.54.suppl_2.S52 www.landesbioscience.com
11. Ziegler AG, Bonifacio E; BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012; 55:1937-43; PMID:22289814; http://dx.doi.org/10.1007/s00125-012-2472-x
12. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, Nelson JL. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104:41-7; PMID:10393697; http://dx.doi. org/10.1172/JCI6611
13. Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-5; PMID:19056990; http://dx.doi.org/10.1126/science.1164511
14. Vanzyl B, Planas R, Ye Y, Foulis A, de Krijger RR, Vives-Pi M, Gillespie KM. Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? Chimerism 2010; 1:45-50; PMID:21327046; http:// dx.doi.org/10.4161/chim.1.2.13891
15. Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007; 104:1637-42; PMID:17244711; http://dx.doi.org/10.1073/pnas.0606169104
16. Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003; 362:1617-23; PMID:14630442; http://dx.doi.org/10.1016/S0140-6736(03)14795-2
17. Dutta P, Molitor-Dart M, Bobadilla JL, Roenneburg DA, Yan Z, Torrealba JR, Burlingham WJ. Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood 2009; 114:3578-87; PMID:19700665; http://dx.doi. org/10.1182/blood-2009-03-213561
18. Stevens AM, Hermes HM, Kiefer MM, Rutledge JC, Nelson JL. Chimeric maternal cells with tissue-specific antigen expression and morphology are common in infant tissues. Pediatr Dev Pathol 2009; 12:337-46; PMID:18939886; http://dx.doi.org/10.2350/08-07-0499.1
19. Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59:2846-53; PMID:20699420; http://dx.doi.org/10.2337/db10-0676
20. Leveque L, Khosrotehrani K. Can maternal micro-chimeric cells influence the fetal response toward self antigens? Chimerism 2011; 2:71-7; PMID:22163064; http://dx.doi.org/10.4161/chim.17589
21. Tiriveedhi V, Weber J, Seetharam A, Mohanakumar T. Cross-talk of alloimmune response and autoimmunity: role in pathogenesis of chronic rejection. Discov Med 2010; 9:229-35; PMID:20350490
22. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza R A, Butler PC. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57:1584-94; PMID:18334605; http://dx.doi. org/10.2337/db07-1369
23. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 2000; 49:1-7; PMID:10615942; http://dx.doi.org/10.2337/ diabetes.49.1.1
24. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49:1325-33; PMID:10923633; http://dx.doi.org/10.2337/diabetes.49.8.1325
25. Roy E, Leduc M, Guegan S, Rachdi L, Kluger N, Scharfmann R, Aractingi S, Khosrotehrani K. Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child. J Autoimmun 2011; 36:253-62; PMID:21414756; http://dx.doi.org/10.1016/j. jaut.2011.02.003
26. Heninger AK, Monti P, Wilhelm C, Schwaiger P, Kuehn D, Ziegler AG, Bonifacio E. Activation of islet autoreactive naïve T cells in infants is influenced by homeostatic mechanisms and antigen presenting capacity. Diabetes 2013; 62:2059-66; PMID:23349478; http://dx.doi.org/10.2337/ db12-0942
27. Planas R, Carrillo J, Sanchez A, de Villa MC, Nuñez F, Verdaguer J, James RF, Pujol-Borrell R, Vives-Pi M. Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 2010; 159:23-44; PMID:19912253; http:// dx.doi.org/10.1111/j.1365-2249.2009.04053.x
28. Bou-Gharios G, Amin F, Hill P, Nakamura H, Maxwell P, Fisk NM. Microchimeric fetal cells are recruited to maternal kidney following injury and activate collagen type I transcription. Cells Tissues Organs 2011; 193:379-92; PMID:21150166; http:// dx.doi.org/10.1159/000321172